期刊文献+

肱骨桡骨骨纤维结构不良1例报告

下载PDF
导出
摘要 1病历摘要患者女,32岁。以“右上肢肿胀不适10天余”为主诉,于2012年11月2日在外院行X线片、MRJ检查(图1,2)。X线片检查结果显示:右肱骨中下段及右桡骨中上段呈囊性膨胀变形。
出处 《中国骨科临床与基础研究杂志》 2013年第2期120-122,共3页 Chinese Orthopaedic Journal of Clinical and Basic Research
  • 相关文献

参考文献10

  • 1Fan QM, Yue B, Bian ZY, et al. The CREB-Smad6-Runx2 axis contributes to the impaired osteogenesis potential of bone marrow stromal cells in fibrous dysplasia of bone [J]. J Pathol, 2012, 228(1): 45-55.
  • 2Liang Q, Wei M, Hodge L, et al. Quantitative analysis of activating alpha subunit of the G protein (Gs) mutation by pyrosequyencing in fibrous dysplasis and other bone lesions [J]. J Mol Diagn, 2011, 13(2): 137-142.
  • 3Pollandt K, Engels C, Kaiser E, et al. Gsalpba gene mutations in monostotic fibrous dysplasia of bone and fibrous dysplasia-like low-grade central osteosarcoma [J]. Virchows Arch, 2001, 439(2): 170-175.
  • 4Yasuoka T, Takagi N, Hatakeyama D, et al. Fibrous dysplasia in the maxilla: possible mechanism of bone remodeling by calcitonin treatment [J]. Oral Oncol, 2003, 39(3): 301-305.
  • 5Taylor RM, Kashima TG, Ferguson D J, et al. Analysis of stromal cells in osteofibrous dysplasia and adamantinoma of long bones [J]. Mod Pathol, 2012, 25(1): 56-64.
  • 6胥少汀,葛宝丰,徐印坎.实用骨科学[M].3版.北京:人民卫生出版社,2005:708-719.
  • 7肖文金,章振林.113例骨纤维结构不良临床分析[J].中国骨质疏松杂志,2008,14(12):887-890. 被引量:8
  • 8管淑敏.骨的纤维结构不良48例临床病理分析[J].吉林医学,2009,30(15):1629-1630. 被引量:2
  • 9胥少汀,朱兵.骨的纤维结构不良的临床特点和处理(附38例分析)[J].中国骨肿瘤骨病,2004,3(6):325-329. 被引量:6
  • 10练克俭,缪建云,程斌,黄连水.异体骨管复合自体髂骨治疗胫骨骨纤维结构不良21例[J].中国中医骨伤科杂志,2011,19(2):45-46. 被引量:1

二级参考文献33

  • 1王贵良,刘东业.骨纤维异常增殖症自发恶变16例分析[J].中国冶金工业医学杂志,2005,22(2):206-207. 被引量:3
  • 2梁晓杰,叶星,纪维纲.上颌骨骨纤维异常增殖症的外科治疗[J].中国耳鼻咽喉头颈外科,2005,12(10):659-660. 被引量:9
  • 3行斌斌,屠重棋,段宏,刘洋,裴福兴.股骨纤维结构不良伴重度内翻畸形的外科治疗[J].中国矫形外科杂志,2007,15(1):24-26. 被引量:6
  • 4Lichtenstein L, Jaffe HL. Fibrous dysplasia of bone. A condition affecting one, several or many bones, the graver cases of which may present abnormal pigmentation of skin, premature sexual development, hyperthyroidism still other extra skeletal abnormalities. Arch Pathol, 1942,33:777-816.
  • 5Kaplan FS, Fallon MD, Boden SD, et al. Estrogen receptors in bone in a patient with polyostotic fibrous dysplasia (McCune-Abfight syndrome). N EngI J Med, 1988, 319(7) :421-425.
  • 6Leer AI, Chebli C, Kushner H, et al. Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome. J Bone Miner Res,2004, 19(4) :571-577.
  • 7Riminucci M, Collins MT, Fedarko NS, et al. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate. J Clin Invest, 2003, 12(5) :683-692.
  • 8Fukumoto S, Yamashita T. FGF23 is a hormone regulating phosphate metabolism-Unique biological characteristics of FGF23. Bone, 2007, 40(5) : 1190-1195.
  • 9Chapurlat RD, Hugueny P, Delmas PD, et al. Treatment of fibrous dysplasia of bone with intravenous parnidronate : long-term effectiveness and evaluation of predictors of response to treatment. Bone, 2004, 35(1):235-242.
  • 10Kobayashi K, Imanishi Y, Koshiyama H, et al. Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia. Life Seienees, 2006,78 (20) : 2295-2301.

共引文献407

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部